Larimar Therapeutics, Inc.
METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND MITOCHONDRIA ASSOCIATED DISEASES
Last updated:
Abstract:
The present disclosure provides methods for treating or ameliorating a myelin associated disease or a mitochondria associated disease that comprising administering to a subject in need thereof a frataxin replacement therapeutic compound, e.g., a fusion protein comprising frataxin.
Status:
Application
Type:
Utility
Filling date:
30 Apr 2021
Issue date:
25 Nov 2021